Added to YB: 2026-09-23
Pitch date: 2026-09-10
109960.KQ [neutral]
APTOCROM Inc.
+0.54%
current return
Author Info
Sung Capital is an alternative asset management firm run by Oliver Sung. We invest capital for families, registered investment advisors, and accredited investors through a private investment fund. We pick underpriced stocks, usually in pockets of the market where large pools of capital (funds and institutions) can’t or won’t invest, but we flip every stone. We pick stocks only, use no leverage, and require a significant margin of safety in every investment. Sign up for the newsletter.
Company Info
APTOCROM Inc. distributes pharmaceutical products in South Korea. It operates through pharmaceutical business, leasing business, and insulation divisions.
Market Cap
KRW 28.1B
Pitch Price
KRW 1.8K
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.11
P/E
0.56
EV/Sales
1.60
Sector
Biotechnology
Category
value
All Korean net nets #3: another 8 stocks - APTOCROM Inc.
109960.KQ (pass): Aptocrom’s 0.44x stated NCAV and 0.08x book valuation mask a balance sheet dominated by related-party exposures: KRW141bn of parent convertibles, KRW107bn of group loans, KRW84bn of unsold-product R&D valued by DCF and KRW16bn of sister-company lease receivables, versus KRW4bn cash. Heavy capital raising and severe retail losses reinforce the decision to avoid the shares.
Read full article (2 min)